Response: Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang et al.)

Detalles Bibliográficos
Autores principales: Jang, Han Na, Jung, Hye Seung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2020
Materias:
Response
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090290/
https://www.ncbi.nlm.nih.gov/pubmed/32207281
http://dx.doi.org/10.3803/EnM.2020.35.1.194
_version_ 1783509901854638080
author Jang, Han Na
Jung, Hye Seung
author_facet Jang, Han Na
Jung, Hye Seung
author_sort Jang, Han Na
collection PubMed
description
format Online
Article
Text
id pubmed-7090290
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Korean Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-70902902020-04-01 Response: Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang et al.) Jang, Han Na Jung, Hye Seung Endocrinol Metab (Seoul) Response Korean Endocrine Society 2020-03 2020-03-19 /pmc/articles/PMC7090290/ /pubmed/32207281 http://dx.doi.org/10.3803/EnM.2020.35.1.194 Text en Copyright © 2020 Korean Endocrine Society http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Response
Jang, Han Na
Jung, Hye Seung
Response: Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang et al.)
title Response: Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang et al.)
title_full Response: Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang et al.)
title_fullStr Response: Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang et al.)
title_full_unstemmed Response: Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang et al.)
title_short Response: Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang et al.)
title_sort response: favorable glycemic control with once-daily insulin degludec/insulin aspart after changing from basal insulin in adults with type 2 diabetes (endocrinol metab 2019; 34:382-9, han na jang et al.)
topic Response
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090290/
https://www.ncbi.nlm.nih.gov/pubmed/32207281
http://dx.doi.org/10.3803/EnM.2020.35.1.194
work_keys_str_mv AT janghanna responsefavorableglycemiccontrolwithoncedailyinsulindegludecinsulinaspartafterchangingfrombasalinsulininadultswithtype2diabetesendocrinolmetab2019343829hannajangetal
AT junghyeseung responsefavorableglycemiccontrolwithoncedailyinsulindegludecinsulinaspartafterchangingfrombasalinsulininadultswithtype2diabetesendocrinolmetab2019343829hannajangetal

Ejemplares similares